We considered whether there are discrete windows of vulnerability in the development of cancer and which time periods may be of the greatest importance. Cancer was considered broadly, including cancers in childhood as well as adult cancers that may have an in utero or childhood origin. We concluded that there was evidence from animal and epidemiologic studies for causal relationships for preconceptional, in utero, and childhood exposures and cancer occurrence in children and adults. However, the evidence is incomplete and all relevant critical windows may not have been identified. The comprehensive evaluation of the relative importance of specific time windows of exposure is limited. Improvements in the design of epidemiologic studies and additional animal studies of mechanisms are warranted. Key words: adult, child, environmental, neoplasm. -Environ Health Perspect 1 08(suppl 3):595-597 (2000) . http.//ehpnetl.niehs.nih.gov/docs/2000/suppl-3/595-597olshan/abstract.html Anderson et al. (1) raised a number of observations and issues on the human epidemiologic and animal evidence for windows of vulnerability in the development of cancer. This report summarizes these observations and issues considered by the cancer breakout group. We considered whether there are discrete windows of vulnerability in the development of cancer and, if so, which time periods are of the greatest importance. We discussed cancer in a broad context, with consideration of cancers in childhood as well as adult cancers that may have an in utero or childhood origin.
Priority Questions
The animal and human epidemiologic findings summarized by Anderson et al. (1) provide evidence for the association between exposures in specific windows and increased risks of cancer in childhood and adulthood. For example, some animal experiments using chemicals or radiation showed that exposure of the male animal before mating with an untreated female results in an excess of offspring with cancer (1) . This finding has a number of implications that have generally not been fully appreciated. First, it shows that exposure to toxicants during the preconception period can result in cancer in the next generation. Second, the experiments indicate that paternal exposures can increase cancer risk in offspring (1) . The area of male-mediated developmental toxicity remains controversial given the inconsistent evidence for association in epidemiologic studies of childhood cancer (1, 2) . Nonetheless, the relatively consistent animal evidence suggests that studies of adult cancer should consider the role of paternal exposures as well as maternal and in utero influences.
The evidence for the in utero period as a critical window is based in large part on the compelling results from the study of diethylstilbestrol and vaginal adenocarcinoma in young women (3) . A number of early studies reported an association between ionizing radiation and leukemia in childhood (4) . Finally, results from the study of Japanese atomic bomb survivors find an increased risk of breast and other cancers in adulthood after childhood exposure to high-dose radiation (5) .
Thus, there appears to be strong evidence from animal and epidemiologic studies for causal relationships including exposure preconceptionally, in utero, and during childhood and cancer occurrence in children and adults. Nevertheless, Table 1 shows that even for the best-studied exposure (ionizing radiation), the evidence is incomplete for certain windows of exposure, in particular prenatal exposures (1) . There is not an analogous childhood in laboratory animals; therefore, most studies relate to adult human tumors on the basis of age of appearance and histology. Nonetheless, animal studies will continue to provide important data on the effects of exposure during various stages before, during, and after pregnancy. Further, these studies are important for their ability to identify susceptibility factors, to establish toxicokinetic models, and to provide mechanistic information (1) .
Gaps in Knowledge
There are a number of gaps in knowledge on exposures in specific windows and increased risk of cancer [reviewed by Anderson et al. (1)]. Table 1 provides clear evidence for the sparseness of the data on ionizing radiation. In human studies there is a dire need for higher quality epidemiologic data on a range of exposures within and across time periods. These gaps exist because of a variety of limitations frequently encountered in epidemiologic studies, such as study size, exposure measurement, confounding, and other biases. Exposure assessment is a serious challenge in two respects. First, most recent studies for childhood cancer have been multicenter case-control studies. Obtaining valid exposure data from parents, often through self-report, remains a major concern. In adult cancer studies, obtaining extensive exposure data for the subject's own pregnancy and childhood or for their parents' preconceptional period is presently in most cases impossible. A basic problem with most epidemiologic studies is the difficulty in accounting for the interaction among exposures within and across time periods. Even for a single exposure, the ability to estimate meaningful effects of an exposure that occurs across multiple time periods can be limited. Currently, there is a great interest in the identification of genetic susceptibility factors in cancer and the role of gene-environment interactions in the development of childhood cancers. For example, a recent study of twins with acute lymphoblastic leukemia used polymerase chain reaction methods to detect a marker of chromosomal translocation and reported that this childhood leukemia is often initiated in utero but requires additional postnatal events (7, 8) . Epidemiologic studies are needed to evaluate the role of gene-environment interactions in these events. In addition, there are few studies of metabolic enzyme polymorphisms and exposures in relation to the risk of childhood cancers (9) . A number of phase I enzymes (cytochrome P450s, for example) involved in the activation of a variety of carcinogens, medications, and other compounds, as well as phase II enzymes (e.g., glutathione S-transferases) that play a role in detoxication are possible candidates for investigation (10) . Polymorphisms of genes involved in the DNA repair process are now available for evaluation (11) . In addition, enzymes that metabolize nutrients, such as 5,1 0-methylenetetrahydrofolate reductase, are also of interest (12 There are further gaps in the experimental animal data: Additional mechanistic information is needed. For example, studies of male exposure to chromium showed an increased incidence of cancer in offspring (1) . However, the mechanism underlying these findings is not clear and an epigenetic mechanism may be of interest. Additional work on the molecular basis of epigenetic phenomena (e.g., methylation and imprinting) and the influence of toxicants on altering these events is warranted (13) . The relationship of experimental studies with human data is not always direct; better linkage is required. Finally, much of the animal data relate to important exposures such as ionizing radiation and other known strong mutagens. However, there is a need to also study a broader range of exposures that may have a different structure-function relationship.
Recommendations
The gaps in knowledge suggest a number of recommendations for future research in this area. Epidemiologic studies can be improved in a number of ways. First, epidemiologists should be more opportunistic in investigating uniquely exposed cohorts. Cohorts such as those defined by occupation, medical treatment, geography, industrial accidents, or other scenarios offer the possibility to study the effects of higher dose, sometimes well-documented, exposures. For rarer cancers, case-control studies are often the design of choice. There is still the need for case-control studies that are populationbased, larger, and with better exposure assessment methodology, although there have been some advances in this respect in recent years. New methods to obtain better occupational exposure data in community based case-control studies have been developed (14) . The development, validation, and application of biomarkers of exposure and effect remain an active area of research (15) . Where possible, studies should attempt to more precisely define potential doseresponse relationships that will facilitate causal evaluation and risk assessment.
Advances in molecular biology provided the tools to investigate genetic susceptibility both in terms of somatic alterations of the tumor (e.g., p53 tumor-suppressor gene mutations) and inherited alterations such as metabolizing enzyme polymorphisms. Epidemiologists should continue to attempt to integrate these tools into field studies. As another example, in some cases of Wilms tumor, a childhood kidney tumor, and retinoblastoma, a childhood eye tumor, the abnormal allele was inherited from the father (16, 14 . Epidemiologic studies could combine methods to identify the parent of origin for the mutation with parental exposure data to define more precisely the etiologic pathway and critical windows of exposure. The rapid development of molecular biology, dissection of the human genome, and databases will provide invaluable resources for these efforts.
Animal studies should continue to investigate specific mechanisms of cancer development with special attention to timing and windows of exposure. These studies can provide invaluable information for our understanding of the development of human cancers. Specific mechanisms such as epigenetic events are of great interest and animal studies offer the possibility to test hypotheses, particularly those related to the effects of endogenous and exogenous exposures. The ability to control the time window of exposure and genetic background should yield new information. These studies would be improved if they were guided, in part, by the findings from epidemiologic studies and explored a greater range of compounds on the basis of mechanism.
